{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:16:21Z","timestamp":1757618181019,"version":"3.44.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n          <jats:p>Die kongestive Nephropathie (CN) ist eine Entit\u00e4t des kardiorenalen Syndroms, die wesentlich auf dem Boden einer ven\u00f6sen Kongestion und neurohormonellen Aktivierung entsteht. Eine Herzinsuffizienz, pulmonalarterielle Hypertonie, isolierte Trikuspidalklappeninsuffizienz und angeborene Herzfehler sind die h\u00e4ufigsten Ursachen. Es gibt bis dato keine allgemein akzeptierten diagnostischen Kriterien, jedoch scheint das Erfassen des intrarenalen ven\u00f6sen Blutflusses mittels Dopplersonographie die geeignetste Methode zu sein. Mit dieser Technik kann ein kontinuierlicher ven\u00f6ser Fluss (keine Kongestion) von den diskontinuierlichen Flussmustern pulsatil (leichte Kongestion), biphasisch (moderate Kongestion) und monophasisch (schwere Kongestion) differenziert werden. Der Venous Impedance Index und der Renal Venous Stasis Index sind zus\u00e4tzliche dopplersonographische Kriterien zum Erfassen einer CN. Therapien mit Schleifendiuretika und\/oder Natrium-Glukose-Kotransporter-2(SGLT-2)-Inhibitoren k\u00f6nnen eine ven\u00f6se Kongestion nachweislich verbessern.<\/jats:p>","DOI":"10.1007\/s00108-025-01894-5","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T06:05:01Z","timestamp":1747721101000},"page":"712-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Kongestive Nephropathie \u2013 Ursachen, Diagnostik und Therapie","Cardiorenal syndrome: causes, diagnosis and treatment of congestive nephropathy"],"prefix":"10.1007","volume":"66","author":[{"given":"Manuel","family":"Wallbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Koziolek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"1894_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.31083\/j.rcm2303111","volume":"23","author":"R Scagliola","year":"2022","unstructured":"Scagliola\u00a0R, Brunelli\u00a0C (2022) Venous Congestion and Systemic Hypoperfusion in Cardiorenal Syndrome: Two Sides of the Same Coin. Rev Cardiovasc Med 23:111","journal-title":"Rev Cardiovasc Med"},{"key":"1894_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.17219\/acem\/144327","volume":"31","author":"A Kosiorek","year":"2022","unstructured":"Kosiorek\u00a0A, Biegus\u00a0J, Rozentryt\u00a0P et\u00a0al (2022) Cardiorenal syndrome: Decongestion in heart failure across wide spectrum of kidney pathophysiology. Adv Clin Exp Med 31:445\u2013455","journal-title":"Adv Clin Exp Med"},{"key":"1894_CR3","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1161\/CIR.0000000000001273","volume":"150","author":"WHW Tang","year":"2024","unstructured":"Tang\u00a0WHW, Bakitas\u00a0MA, Cheng\u00a0XS et\u00a0al (2024) Evaluation and Management of Kidney Dysfunction in Advanced Heart Failure: A\u00a0Scientific Statement From the American Heart Association. Circulation 150:e280\u2013e295","journal-title":"Circulation"},{"key":"1894_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","volume":"53","author":"W Mullens","year":"2009","unstructured":"Mullens\u00a0W, Abrahams\u00a0Z, Francis\u00a0GS et\u00a0al (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J\u00a0Am Coll Cardiol 53:589\u2013596","journal-title":"J Am Coll Cardiol"},{"key":"1894_CR5","doi-asserted-by":"crossref","unstructured":"L DM (2022) Congestive Nephropathy. International journal of environmental research and public health 19","DOI":"10.3390\/ijerph19052499"},{"key":"1894_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ehf2.13118","volume":"8","author":"F Husain-Syed","year":"2021","unstructured":"Husain-Syed\u00a0F, Grone\u00a0HJ, Assmus\u00a0B et\u00a0al (2021) Congestive nephropathy: a\u00a0neglected entity? Proposal for diagnostic criteria and future perspectives. Esc Heart Fail 8:183\u2013203","journal-title":"Esc Heart Fail"},{"key":"1894_CR7","first-page":"786","volume":"11","author":"ER Argaiz","year":"2022","unstructured":"Argaiz\u00a0ER, Rola\u00a0P, Haycock\u00a0KH et\u00a0al (2022) Fluid management in acute kidney injury: from evaluating fluid responsiveness towards assessment of fluid tolerance. Eur Heart Journal Acute Cardiovasc Care 11:786\u2013793","journal-title":"Eur Heart Journal Acute Cardiovasc Care"},{"key":"1894_CR8","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jacc.2008.08.080","volume":"53","author":"K Damman","year":"2009","unstructured":"Damman\u00a0K, Van Deursen\u00a0VM, Navis\u00a0G et\u00a0al (2009) Increased central venous pressure is associated with impaired renal function and mortality in a\u00a0broad spectrum of patients with cardiovascular disease. J\u00a0Am Coll Cardiol 53:582\u2013588","journal-title":"J Am Coll Cardiol"},{"key":"1894_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1159\/000534976","volume":"13","author":"ER Argaiz","year":"2023","unstructured":"Argaiz\u00a0ER, Romero-Gonzalez\u00a0G, Rola\u00a0P et\u00a0al (2023) Bedside Ultrasound in the Management of Cardiorenal Syndromes: An Updated Review. Cardiorenal Med 13:372\u2013384","journal-title":"Cardiorenal Med"},{"key":"1894_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.33549\/physiolres.935110","volume":"73","author":"K Buryskova Salajova","year":"2024","unstructured":"Buryskova Salajova\u00a0K, Malik\u00a0J, Valerianova\u00a0A (2024) Cardiorenal Syndromes and Their Role in Water and Sodium Homeostasis. Physiol Res 73:173\u2013187","journal-title":"Physiol Res"},{"key":"1894_CR11","doi-asserted-by":"publisher","first-page":"101509","DOI":"10.1016\/j.cpcardiol.2022.101509","volume":"48","author":"JA Kim","year":"2023","unstructured":"Kim\u00a0JA, Wu\u00a0L, Rodriguez\u00a0M et\u00a0al (2023) Recent Developments in the Evaluation and Management of Cardiorenal Syndrome: A\u00a0Comprehensive Review. Curr Probl Cardiol 48:101509","journal-title":"Curr Probl Cardiol"},{"key":"1894_CR12","series-title":"Association","first-page":"10","volume-title":"Acute kidney injury in acute heart failure-when to worry and when not to worry? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association\u2014European Renal","author":"D Banerjee","year":"2024","unstructured":"Banerjee\u00a0D, Ali\u00a0MA, Wang\u00a0AY et\u00a0al (2024) Acute kidney injury in acute heart failure-when to worry and when not to worry? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association\u2014European Renal. Association, Bd. 40, S\u00a010\u201318"},{"key":"1894_CR13","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00392-023-02184-6","volume":"112","author":"M Wallbach","year":"2023","unstructured":"Wallbach\u00a0M, Valentova\u00a0M, Schroeter\u00a0MR et\u00a0al (2023) Intrarenal Doppler ultrasonography in patients with HFrEF and acute decompensated heart failure undergoing recompensation. Clin Res Cardiol 112:1087\u20131095","journal-title":"Clin Res Cardiol"},{"key":"1894_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/ejhf.2032","volume":"23","author":"P Pellicori","year":"2021","unstructured":"Pellicori\u00a0P, Platz\u00a0E, Dauw\u00a0J et\u00a0al (2021) Ultrasound imaging of congestion in heart failure: examinations beyond the heart. European J of Heart Fail 23:703\u2013712","journal-title":"European J of Heart Fail"},{"key":"1894_CR15","doi-asserted-by":"publisher","first-page":"772466","DOI":"10.3389\/fcvm.2022.772466","volume":"9","author":"H Ohara","year":"2022","unstructured":"Ohara\u00a0H, Yoshihisa\u00a0A, Horikoshi\u00a0Y et\u00a0al (2022) Renal Venous Stasis Index Reflects Renal Congestion and Predicts Adverse Outcomes in Patients With Heart Failure. Front Cardiovasc Med 9:772466","journal-title":"Front Cardiovasc Med"},{"key":"1894_CR16","first-page":"350","volume":"14","author":"A Koratala","year":"2024","unstructured":"Koratala\u00a0A, Romero-Gonzalez\u00a0G, Soliman-Aboumarie\u00a0H et\u00a0al (2024) Unlocking the Potential of VExUS in Assessing Venous Congestion: The Art of Doing It Right. Cardiorenal Med 14:350\u2013374","journal-title":"Cardiorenal Med"},{"key":"1894_CR17","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jchf.2017.05.006","volume":"5","author":"P Nijst","year":"2017","unstructured":"Nijst\u00a0P, Martens\u00a0P, Dupont\u00a0M et\u00a0al (2017) Intrarenal Flow Alterations During Transition From Euvolemia to Intravascular Volume Expansion in Heart Failure Patients. Jacc Heart Fail 5:672\u2013681","journal-title":"Jacc Heart Fail"},{"key":"1894_CR18","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/ejhf.1492","volume":"21","author":"O Chioncel","year":"2019","unstructured":"Chioncel\u00a0O, Mebazaa\u00a0A, Maggioni\u00a0AP et\u00a0al (2019) Acute heart failure congestion and perfusion status\u2014impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry. European J of Heart Fail 21:1338\u20131352","journal-title":"European J of Heart Fail"},{"key":"1894_CR19","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1002\/ehf2.14760","volume":"11","author":"F Husain-Syed","year":"2024","unstructured":"Husain-Syed\u00a0F, Rangaswami\u00a0J, Nunez\u00a0J et\u00a0al (2024) Histopathology of congestive nephropathy: a\u00a0case description and literature review. Esc Heart Fail 11:2395\u20132398","journal-title":"Esc Heart Fail"},{"key":"1894_CR20","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/ejhf.1697","volume":"22","author":"W Mullens","year":"2020","unstructured":"Mullens\u00a0W, Damman\u00a0K, Testani\u00a0JM et\u00a0al (2020) Evaluation of kidney function throughout the heart failure trajectory\u2014a\u00a0position statement from the Heart Failure Association of the European Society of Cardiology. European J of Heart Fail 22:584\u2013603","journal-title":"European J of Heart Fail"},{"key":"1894_CR21","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA Mcdonagh","year":"2021","unstructured":"Mcdonagh\u00a0TA, Metra\u00a0M, Adamo\u00a0M et\u00a0al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart\u00a0J 42:3599\u20133726","journal-title":"Eur Heart J"},{"key":"1894_CR22","first-page":"185","volume":"38","author":"T Tabucanon","year":"2020","unstructured":"Tabucanon\u00a0T, Tang\u00a0WHW (2020) Right Heart Failure and Cardiorenal Syndrome. Cardiol Clin 38:185\u2013202","journal-title":"Cardiol Clin"},{"key":"1894_CR23","doi-asserted-by":"publisher","first-page":"114058","DOI":"10.1016\/j.biopha.2022.114058","volume":"157","author":"L Guo","year":"2023","unstructured":"Guo\u00a0L, Fu\u00a0B, Liu\u00a0Y et\u00a0al (2023) Diuretic resistance in patients with kidney disease: Challenges and opportunities. Biomed Pharmacother = Biomedecine Pharmacother 157:114058","journal-title":"Biomed Pharmacother = Biomedecine Pharmacother"},{"key":"1894_CR24","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1005419","volume":"364","author":"GM Felker","year":"2011","unstructured":"Felker\u00a0GM, Lee\u00a0KL, Bull\u00a0DA et\u00a0al (2011) Diuretic strategies in patients with acute decompensated heart failure. N\u00a0Engl J Med 364:797\u2013805","journal-title":"N Engl J Med"},{"key":"1894_CR25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10741-020-10057-7","volume":"26","author":"B Wobbe","year":"2021","unstructured":"Wobbe\u00a0B, Wagner\u00a0J, Szabo\u00a0DK et\u00a0al (2021) Ultrafiltration is better than diuretic therapy for volume-overloaded acute heart failure patients: a\u00a0meta-analysis. Heart Fail Rev 26:577\u2013585","journal-title":"Heart Fail Rev"},{"key":"1894_CR26","doi-asserted-by":"publisher","first-page":"1281107","DOI":"10.3389\/fendo.2023.1281107","volume":"14","author":"ES Speedtsberg","year":"2023","unstructured":"Speedtsberg\u00a0ES, Tepel\u00a0M (2023) Narrative review investigating the nephroprotective mechanisms of sodium glucose cotransporter type\u00a02\u00a0inhibitors in diabetic and nondiabetic patients with chronic kidney disease. Front Endocrinol 14:1281107","journal-title":"Front Endocrinol"},{"key":"1894_CR27","doi-asserted-by":"publisher","first-page":"sfae234","DOI":"10.1093\/ckj\/sfae234","volume":"17","author":"M Wallbach","year":"2024","unstructured":"Wallbach\u00a0M, Ajrab\u00a0J, Bayram\u00a0B et\u00a0al (2024) Effects of SGLT2 inhibitors on parameters of renal venous congestion in intrarenal Doppler ultrasonography. Clin Kidney\u00a0J 17:sfae234","journal-title":"Clin Kidney J"},{"key":"1894_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1253\/circrep.CR-22-0118","volume":"5","author":"R Matsukawa","year":"2023","unstructured":"Matsukawa\u00a0R, Okahara\u00a0A, Tokutome\u00a0M et\u00a0al (2023) Early Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Leads to a\u00a0Shorter Hospital Stay in Patients With Acute Decompensated Heart Failure. Circ Reports 5:187\u2013197","journal-title":"Circ Reports"},{"key":"1894_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41440-023-01437-1","volume":"47","author":"A Endo","year":"2024","unstructured":"Endo\u00a0A, Hirose\u00a0T, Sato\u00a0S et\u00a0al (2024) Sodium glucose cotransporter 2 inhibitor suppresses renal injury in rats with renal congestion. Hypertens Res 47:33\u201345","journal-title":"Hypertens Res"},{"key":"1894_CR30","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","volume":"387","author":"W Mullens","year":"2022","unstructured":"Mullens\u00a0W, Dauw\u00a0J, Martens\u00a0P et\u00a0al (2022) Acetazolamide in Acute Decompensated Heart Failure with Volume Overload. N\u00a0Engl J Med 387:1185\u20131195","journal-title":"N Engl J Med"},{"key":"1894_CR31","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/eurheartj\/ehv010","volume":"36","author":"K Damman","year":"2015","unstructured":"Damman\u00a0K, Testani\u00a0JM (2015) The kidney in heart failure: an update. Eur Heart\u00a0J 36:1437\u20131444","journal-title":"Eur Heart J"},{"key":"1894_CR32","first-page":"320","volume":"14","author":"LY Villegas-Gutierrez","year":"2024","unstructured":"Villegas-Gutierrez\u00a0LY, Nunez\u00a0J, Kashani\u00a0K et\u00a0al (2024) Kidney Replacement Therapies and Ultrafiltration in Cardiorenal Syndrome. Cardiorenal Med 14:320\u2013333","journal-title":"Cardiorenal Med"},{"key":"1894_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.109.933275","volume":"122","author":"JM Testani","year":"2010","unstructured":"Testani\u00a0JM, Chen\u00a0J, Mccauley\u00a0BD et\u00a0al (2010) Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122:265\u2013272","journal-title":"Circulation"},{"key":"1894_CR34","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1161\/CIRCULATIONAHA.117.030112","volume":"137","author":"T Ahmad","year":"2018","unstructured":"Ahmad\u00a0T, Jackson\u00a0K, Rao\u00a0VS et\u00a0al (2018) Worsening renal function in patients with acute heart failure undergoing aggressive diuresis is not associated with tubular injury. Circulation 137:2016\u20132028","journal-title":"Circulation"},{"key":"1894_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejim.2024.10.024","volume":"131","author":"R Sato","year":"2025","unstructured":"Sato\u00a0R, Koziolek\u00a0MJ, Von Haehling\u00a0S (2025) Translating evidence into practice: Managing electrolyte imbalances and iron deficiency in heart failure. Eur J Intern Med 131:15\u201326","journal-title":"Eur J Intern Med"},{"key":"1894_CR36","first-page":"235","volume":"14","author":"Z Blazquez-Bermejo","year":"2024","unstructured":"Blazquez-Bermejo\u00a0Z, Quiroga\u00a0B, Casado\u00a0J et\u00a0al (2024) Practical Approaches to the Management of Cardiorenal Disease beyond Congestion. Cardiorenal Med 14:235\u2013250","journal-title":"Cardiorenal Med"},{"key":"1894_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s42399-022-01347-2","volume":"5","author":"A Minciunescu","year":"2023","unstructured":"Minciunescu\u00a0A, Genovese\u00a0L, Defilippi\u00a0C (2023) Cardiovascular Alterations and Structural Changes in the Setting of Chronic Kidney Disease: a\u00a0Review of Cardiorenal Syndrome Type\u00a04. Sn Compr Clin Med 5:15","journal-title":"Sn Compr Clin Med"},{"key":"1894_CR38","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.kint.2019.02.022","volume":"95","author":"AA House","year":"2019","unstructured":"House\u00a0AA, Wanner\u00a0C, Sarnak\u00a0MJ et\u00a0al (2019) Heart failure in chronic kidney disease: conclusions from a\u00a0Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 95:1304\u20131317","journal-title":"Kidney Int"},{"issue":"i149","key":"1894_CR39","first-page":"i153","volume":"27","author":"G Cice","year":"2025","unstructured":"Cice\u00a0G, Calo\u00a0L (2025) Can we slow down the decline in renal function? Eur Heart J Suppl : J Eur Soc Cardiol 27(i149):i153","journal-title":"Eur Heart J Suppl : J Eur Soc Cardiol"},{"key":"1894_CR40","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink\u00a0HJL, Stefansson\u00a0BV, Correa-Rotter\u00a0R et\u00a0al (2020) Dapagliflozin in patients with chronic kidney disease. N\u00a0Engl J Med 383:1436\u20131446","journal-title":"N Engl J Med"},{"key":"1894_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"T E-KCG","year":"2023","unstructured":"E\u2011KCG T, Herrington\u00a0WG, Staplin\u00a0N et\u00a0al (2023) Empagliflozin in Patients with Chronic Kidney Disease. N\u00a0Engl J Med 388:117\u2013127","journal-title":"N Engl J Med"},{"key":"1894_CR42","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","volume":"385","author":"B Pitt","year":"2021","unstructured":"Pitt\u00a0B, Filippatos\u00a0G, Agarwal\u00a0R et\u00a0al (2021) Cardiovascular Events with Finerenone in Kidney Disease and Type\u00a02 Diabetes. N\u00a0Engl J Med 385:2252\u20132263","journal-title":"N Engl J Med"},{"key":"1894_CR43","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/MNH.0000000000000920","volume":"32","author":"B Lucas","year":"2023","unstructured":"Lucas\u00a0B, Taal\u00a0MW (2023) Blood pressure targets in chronic kidney disease: still no consensus. Curr Opin Nephrol Hypertens 32:497\u2013501","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1894_CR44","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1161\/HYPERTENSIONAHA.121.16503","volume":"77","author":"K Raby","year":"2021","unstructured":"Raby\u00a0K, Rocco\u00a0M, Oparil\u00a0S et\u00a0al (2021) Heart Failure Primary Prevention: What Does SPRINT Add?: Recent Advances in Hypertension. Hypertension 77:1804\u20131814","journal-title":"Hypertension"},{"key":"1894_CR45","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2215\/CJN.0000000000000335","volume":"19","author":"PE Drawz","year":"2024","unstructured":"Drawz\u00a0PE, Lenoir\u00a0KM, Rai\u00a0NK et\u00a0al (2024) Effect of Intensive Blood Pressure Control on Kidney Outcomes: Long-Term Electronic Health Record-Based Post-Trial Follow-Up of SPRINT. Clin J Am Soc Nephrol 19:213\u2013223","journal-title":"Clin J Am Soc Nephrol"},{"key":"1894_CR46","doi-asserted-by":"crossref","unstructured":"Haonan L, Qiaorui H, Wenqing Z et\u00a0al (2025) Association of baseline eGFR and incident heart failure on patients receiving intensive blood pressure treatment. Esc Heart Fail","DOI":"10.1002\/ehf2.15232"},{"key":"1894_CR47","doi-asserted-by":"crossref","unstructured":"Ngo K, Kotecha D, Walters JA et\u00a0al (2010) Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients. Cochrane Database Syst Rev CD007613:","DOI":"10.1002\/14651858.CD007613.pub2"},{"key":"1894_CR48","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1681\/ASN.0000000000000321","volume":"35","author":"JW Cunningham","year":"2024","unstructured":"Cunningham\u00a0JW, Claggett\u00a0BL, Lopes\u00a0RD et\u00a0al (2024) Daprodustat and Heart Failure in CKD. J\u00a0Am Soc Nephrol 35:607\u2013617","journal-title":"J Am Soc Nephrol"},{"key":"1894_CR49","doi-asserted-by":"publisher","first-page":"1146668","DOI":"10.3389\/fphar.2023.1146668","volume":"14","author":"YL Cheng","year":"2023","unstructured":"Cheng\u00a0YL, Huang\u00a0SC, Ho\u00a0MY et\u00a0al (2023) Effect of sodium bicarbonate on cardiovascular outcome and mortality in patients with advanced chronic kidney disease. Front Pharmacol 14:1146668","journal-title":"Front Pharmacol"},{"key":"1894_CR50","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.xkme.2021.04.011","volume":"3","author":"D Collister","year":"2021","unstructured":"Collister\u00a0D, Ferguson\u00a0TW, Funk\u00a0SE et\u00a0al (2021) Metabolic Acidosis and Cardiovascular Disease in CKD. Kidney Med 3:753\u2013761","journal-title":"Kidney Med"},{"key":"1894_CR51","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","volume":"105","author":"A Levin","year":"2024","unstructured":"Levin\u00a0A, Ahmed\u00a0SB, Carrero\u00a0JJ et\u00a0al (2024) Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns. Kidney Int 105:684\u2013701","journal-title":"Kidney Int"},{"key":"1894_CR52","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s40620-023-01626-8","volume":"36","author":"FA Alexandre","year":"2023","unstructured":"Alexandre\u00a0FA, Stoelzel\u00a0M, Kiran\u00a0A et\u00a0al (2023) Clinical factors for predicting cardiovascular risk, need for renal replacement therapy, and mortality in patients with non-dialysis-dependent stage\u00a03\u20135 chronic kidney disease from the Salford Kidney Study. J\u00a0Nephrol 36:1639\u20131649","journal-title":"J Nephrol"},{"key":"1894_CR53","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000505717","volume":"51","author":"NM Lioufas","year":"2020","unstructured":"Lioufas\u00a0NM, Pedagogos\u00a0E, Hawley\u00a0CM et\u00a0al (2020) Aortic Calcification and Arterial Stiffness Burden in a\u00a0Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the Impact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial. Am J Nephrol 51:201\u2013215","journal-title":"Am J Nephrol"},{"key":"1894_CR54","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12882-021-02312-2","volume":"22","author":"H Eddington","year":"2021","unstructured":"Eddington\u00a0H, Chinnadurai\u00a0R, Alderson\u00a0H et\u00a0al (2021) A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism. BMC Nephrol 22:106","journal-title":"BMC Nephrol"},{"key":"1894_CR55","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1093\/ndt\/gfad043","volume":"38","author":"AY Wang","year":"2023","unstructured":"Wang\u00a0AY, Lo\u00a0WK, Cheung\u00a0SC et\u00a0al (2023) Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a\u00a0randomized trial. Nephrol Dial Transplant : Off Publ Eur Dial Transpl Assoc Ren Assoc 38:1823\u20131835","journal-title":"Nephrol Dial Transplant : Off Publ Eur Dial Transpl Assoc Ren Assoc"},{"key":"1894_CR56","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1001\/archinte.1913.00060260002001","volume":"6","author":"Rowntree LF, R.; Geraghty, Jt","year":"1913","unstructured":"Rowntree LF, R.; Geraghty, Jt (1913) The effects of experimental chronic passive congestion on renal function. Arch Intern Med (chic) 6:121\u2013147","journal-title":"Arch Intern Med (chic)"},{"key":"1894_CR57","unstructured":"Ajrab J (2025) Prospektive Untersuchung von prognostischen Markern des Nierenschadens beim kardiorenalen Syndrom: Erfassung der Auswirkung von SGLT2-Inhibitoren auf Parameter der renalen Kongestion. Dissertation, Georg-August-Universit\u00e4t, G\u00f6ttingen"},{"key":"1894_CR58","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) (2024) KDIGO 2025 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD) \u2013 Public Review Draft. https:\/\/kdigo.org\/wp-content\/uploads\/2024\/11\/KDIGO-2025-Anemia-in-CKD-Guideline_Public-Review-Draft_Nov42024.pdf"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01894-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-025-01894-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01894-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:43:21Z","timestamp":1757173401000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-025-01894-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1894"],"URL":"https:\/\/doi.org\/10.1007\/s00108-025-01894-5","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"type":"print","value":"2731-7080"},{"type":"electronic","value":"2731-7099"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"20 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"M.\u00a0Wallbach: A. Finanzielle Interessen: Forschungsf\u00f6rderungen von Novartis und CVRx. \u2013\u00a0Referentenhonorare von AstraZeneca, Boehringer Ingelheim, CSL Vifor, CVRx, Novartis.\u00a0\u2013 B. Nichtfinanzielle Interessen: Angestellter Facharzt f\u00fcr Innere Medizin\/Nephrologie, Universit\u00e4tsmedizin G\u00f6ttingen, G\u00f6ttingen | Mitgliedschaften: Deutsche Hochdruckliga (DHL), Deutsche Gesellschaft f\u00fcr Nephrologie (DGfN). M.\u00a0Koziolek: A. Finanzielle Interessen: Forschungsf\u00f6rderungen von Novartis und CVRx. \u2013\u00a0Referentenhonorare von AstraZeneca, Boehringer Ingelheim, CSL Vifor , CVRx, Janssen-Cilag, Lilly, Novartis, Pfizer, Servier.\u00a0\u2013 B. Nichtfinanzielle Interessen: Angestellter Facharzt f\u00fcr Innere Medizin\/Nephrologie, Universit\u00e4tsmedizin G\u00f6ttingen, G\u00f6ttingen | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Innere Medizin (DGIM), DHL, DGfN. S.\u00a0von Haehling: A. Finanzielle Interessen: Forschungsf\u00f6rderung von Deutsches Zentrum f\u00fcr Herz-Kreislauf-Forschung (DZHK), Innovative Medicine Initiative (IMI), Boehringer, AstraZeneca, Pharmacosmos, Amgen und Novo Nordisk. \u2013\u00a0S.\u00a0von Haehling erhielt Honorarzahlungen von AstraZeneca, Bayer, Boehringer Ingelheim, BRAHMS, Edwards Lifesciences, MSD, Novartis, Novo Nordisk, Pfizer, Pharmacosmos und Vifor.\u00a0\u2013 S.\u00a0von Haehling ist Berater f\u00fcr AstraZeneca, Bayer, Boehringer Ingelheim, BRAHMS, Edwards Lifesciences, MSD, Novartis, Novo Nordisk, Pfizer, Pharmacosmos, und Vifor. \u2013\u00a0Aktienanteile an Actimed.\u00a0\u2013 B. Nichtfinanzielle Interessen: Angestellter Kardiologe, Klinik f\u00fcr Kardiologie und Pneumologie, Universit\u00e4tsmedizin G\u00f6ttingen.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}